IPG-MOXIFLOXACIN TABLET

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)

から入手可能:

MARCAN PHARMACEUTICALS INC

ATCコード:

J01MA14

INN（国際名）:

MOXIFLOXACIN

投薬量:

400MG

医薬品形態:

TABLET

構図:

MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400MG

投与経路:

ORAL

パッケージ内のユニット:

30/500

処方タイプ:

Prescription

治療領域:

QUINOLONES

製品概要:

Active ingredient group (AIG) number: 0142242001; AHFS:

認証ステータス:

APPROVED

承認日:

2016-03-21

製品の特徴

PRODUCT MONOGRAPH
PR
IPG-MOXIFLOXACIN
400mg Moxifloxacin (as Moxifloxacin hydrochloride) tablets
(Professed)
Antibacterial Agent
Marcan Pharmaceuticals Inc. Date of Revision: March 12, 2020
2 Gurdwara Rd, # 112
Ottawa, Ontario
K2E 1A2, Canada
www.marcanpharma.com
CONTROL# 236676
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.............................................................................
3
SUMMARY PRODUCT INFORMATION
..............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
.........................................................................................................................
6
WARNINGS AND PRECAUTIONS
.......................................................................................................
6
ADVERSE REACTIONS
.......................................................................................................................
14
DRUG INTERACTIONS
........................................................................................................................
18
DOSAGE AND ADMINISTRATION
....................................................................................................
21
OVERDOSAGE
......................................................................................................................................
22
ACTION AND CLINICAL PHARMACOLOGY
..................................................................................
23
STORAGE AND STABILITY
...............................................................................................................
30
SPECIAL HANDLING INSTRUCTIONS
.............................................................................................
30
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................................... 30
PART II: SCIENTIFIC INFORMATION
.............